Feeding a growing global population requires sustainable, innovative, and cost-effective solutions, especially in light of the environmental damage and nutrient imbalances caused by excessive chemical fertilizer use. Microalgae have gained prominence due to their phylogenetic diversity, physiological adaptability, eco-compatible characteristics, and potential to support regenerative agriculture and mitigate climate change. Functioning as biofertilizers, biostimulants, and bioremediators, microalgae accelerate nutrient cycling, improve soil aggregation through extracellular polymeric substances (EPSs), and stimulate rhizospheric microbial diversity. Empirical studies demonstrate their ability to increase crop yields by 5–25%, reduce chemical nitrogen inputs by up to 50%, and boost both organic carbon content and enzymatic activity in soils. Their application in saline and degraded lands further promotes resilience and ecological regeneration. Microalgal cultivation platforms offer scalable in situ carbon sequestration, converting atmospheric carbon dioxide (CO₂) into biomass with potential downstream vaporization into biofuels, bioplastics, and biochar, aligning with circular economy principles. While the commercial viability of microalgae is challenged by high production costs, technical complexities, and regulatory gaps, recent breakthroughs in cultivation systems, biorefinery integration, and strain optimization highlight promising pathways forward. This review highlights the strategic importance of microalgae in enhancing climate resilience, promoting agricultural sustainability, restoring soil health, and driving global bioeconomic transformation.

Background: Ultraviolet-C (UV-C) radiation is a high-energy physical mutagen capable of inducing DNA damage and oxidative stress, thereby generating genomic variability in photosynthetic organisms. However, its genome-wide effects in unicellular eukaryotic microalgae remain poorly characterized. This study developed a UV-C mutagenesis protocol in Chlamydomonas reinhardtii and evaluated its genomic and physiological impacts. Methods: Axenic cultures of Chlamydomonas reinhardtii (137c+) were exposed to UV-C (100–280 nm) for 12, 48, and 96 min. Viable colonies were analyzed by Random Amplification of Polymorphic DNA PCR (RAPD-PCR) to assess genetic variability, while chlorophyll content and the expression of stress-responsive genes were measured via spectrophotometry and Reverse Transcription quantitative Polymerase Chain Reaction (RT-qPCR), respectively. Results: UV-C treatment induced extensive genomic polymorphism with heterogeneous clustering patterns independent of exposure time, consistent with stochastic mutagenesis. Several mutants exhibited reduced chlorophyll content, indicating impaired photosynthetic efficiency. In contrast, one genotype (pop18) maintained wild-type chlorophyll levels despite marked genetic divergence, coupled with upregulation of antioxidant, DNA repair, and stress-response genes. Conclusions: Overall, UV-C irradiation represents an effective approach to generate non-directional genomic variability in Chlamydomonas reinhardtii, with evidence that random mutagenesis can drive functional reorganization of stress-response pathways, supporting its application in microalgal strain improvement.

Comprising multiple microorganisms, the microbiota plays a crucial role in regulating the immune system and maintaining homeostasis. The influence of genetic and environmental factors causes the composition of the microbiota to change throughout life, which is called the plasticity of the microbiota. A eubiotic microbiota promotes the immune response, reducing the risk of inflammation and diseases such as IBD and cancer. The Mediterranean diet is of fundamental importance for a healthy microbiota. On the contrary, Western diets lead to microbiota dysbiosis and inflammation. Microalgae, and, in particular, their derivatives, show promise and relevance in the search for potential anti-inflammatory and antioxidant biomolecules. This review focuses on the correlation between microbiota, nutrition, immunity and microalgal derivatives, highlighting how these may be a potential innovative therapeutic strategy for the management of chronic inflammatory diseases.